Arthur Krieg to Oligonucleotides, Antisense
This is a "connection" page, showing publications Arthur Krieg has written about Oligonucleotides, Antisense.
Connection Strength
2.143
-
Aartsma-Rus A, Krieg AM. Advancing Nucleic Acid Therapeutics by Setting Uniform Standards for Experimental Controls. Nucleic Acid Ther. 2019 06; 29(3):115.
Score: 0.580
-
Subramanian RR, Wysk MA, Ogilvie KM, Bhat A, Kuang B, Rockel TD, Weber M, Uhlmann E, Krieg AM. Enhancing antisense efficacy with multimers and multi-targeting oligonucleotides (MTOs) using cleavable linkers. Nucleic Acids Res. 2015 Oct 30; 43(19):9123-32.
Score: 0.455
-
Goyenvalle A, Jimenez-Mallebrera C, van Roon W, Sewing S, Krieg AM, Arechavala-Gomeza V, Andersson P. Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides. Nucleic Acid Ther. 2023 01; 33(1):1-16.
Score: 0.188
-
Zhao Q, Song X, Waldschmidt T, Fisher E, Krieg AM. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation. Blood. 1996 Sep 01; 88(5):1788-95.
Score: 0.121
-
Krieg AM, Matson S, Fisher E. Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs. Antisense Nucleic Acid Drug Dev. 1996; 6(2):133-9.
Score: 0.116
-
Bishop WP, Lin J, Stein CA, Krieg AM. Interruption of a transforming growth factor alpha autocrine loop in Caco-2 cells by antisense oligodeoxynucleotides. Gastroenterology. 1995 Dec; 109(6):1882-9.
Score: 0.115
-
Krieg AM, Stein CA. Phosphorothioate oligodeoxynucleotides: antisense or anti-protein? Antisense Res Dev. 1995; 5(4):241.
Score: 0.108
-
Teasdale RM, Matson SJ, Fisher E, Krieg AM. Inhibition of T4 polynucleotide kinase activity by phosphorothioate and chimeric oligodeoxynucleotides. Antisense Res Dev. 1994; 4(4):295-7.
Score: 0.101
-
Krieg AM, Tonkinson J, Matson S, Zhao Q, Saxon M, Zhang LM, Bhanja U, Yakubov L, Stein CA. Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy. Proc Natl Acad Sci U S A. 1993 Feb 01; 90(3):1048-52.
Score: 0.094
-
Zhao Q, Matson S, Herrera CJ, Fisher E, Yu H, Krieg AM. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res Dev. 1993; 3(1):53-66.
Score: 0.094
-
Matson S, Krieg AM. Nonspecific suppression of [3H]thymidine incorporation by "control" oligonucleotides. Antisense Res Dev. 1992; 2(4):325-30.
Score: 0.088
-
Eckstein F, Krieg AM, Stein CA, Agrawal S, Beaucage S, Cook PD, Crooke S, Gait MJ, Gewirtz A, H?l?ne C, Miller P, Narayanan R, Nicolin A, Nielsen P, Ohtsuka E, Seliger H, Stec W, Tidd D, Wagner R, Zon J. On the quality control of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 1996; 6(3):149.
Score: 0.029
-
Mojcik CF, Gourley MF, Klinman DM, Krieg AM, Gmelig-Meyling F, Steinberg AD. Administration of a phosphorothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific manner. Clin Immunol Immunopathol. 1993 May; 67(2):130-6.
Score: 0.024
-
Krieg AM, Gause WC, Gourley MF, Steinberg AD. A role for endogenous retroviral sequences in the regulation of lymphocyte activation. J Immunol. 1989 Oct 15; 143(8):2448-51.
Score: 0.019
-
Gourley MF, Kisch WJ, Mojcik CF, King LB, Krieg AM, Steinberg AD. Role of endogenous retroviruses in autoimmune diseases. Tohoku J Exp Med. 1994 May; 173(1):105-14.
Score: 0.006
-
Louie SW, Ramirez LM, Krieg AM, Maliszewski CR, Bishop GA. Endogenous secretion of IL-4 maintains growth and Thy-1 expression of a transformed B cell clone. J Immunol. 1993 Jan 15; 150(2):399-406.
Score: 0.006